All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Assure system, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Kestra Medical
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Assure system, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.5 for the broader beat in this window. Their average consequence score of 6 runs above the beat's 5.8 for that window. Kestra Medical appears in 1 tracked Healthcare story from March 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Kestra Medical. Shared-story counts are live from our verified record — not editorial picks.
Kestra Medical (KMTS) delivered a robust Q3 2026 with $24.6 million in revenue, driven by a 58% surge in Assure system prescriptions. Despite a widening net loss of $34.2 million, the company secured critical access to the VA Federal Supply Schedule and expanded its Florida Medicaid footprint.